AGL agilon health, inc.
Services-Misc Health & Allied Services, NEC · NYSE · SEC CIK 1831097 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY2.0%
TTM net income YoY71.7%
TTM EPS YoY73.5%
Revenue 3-yr CAGR15.0%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-2.6%
Net margin-1.5%
FCF margin-0.3%
EBITDA margin-2.1%
Returns
ROE-29.7%
ROA-5.5%
ROIC (approx.)-79.4%
Asset turnover3.80x
Leverage & solvency
Liabilities / assets82.1%
Debt / equity0.11x
Current ratio1.13x
Interest coverage-22.38x
Cash quality & payout
Operating cash flow / net income0.05x
Accruals ratio-5.2%
Payout ratio—
Capex / revenue0.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $5.93B | $6.06B |
| SG&A expense | $238.54M | $268.91M |
| Operating income | -$463.24M | -$292.13M |
| Interest expense | $6.64M | $6.18M |
| Pretax income | -$404.10M | -$248.83M |
| Income tax | $1.25M | $1.45M |
| Net income | -$391.35M | -$260.15M |
| EBITDA | -$434.64M | -$267.67M |
| EPS (diluted) | — | — |
| Weighted avg. shares (diluted) | 413.97M | 410.97M |
| Balance sheet | ||
| Cash & equivalents | $173.71M | $188.23M |
| Receivables | $673.79M | $1.02B |
| Current assets | $1.10B | $1.46B |
| PP&E, net | $25.42M | $28.17M |
| Goodwill | $0 | $24.13M |
| Intangibles | $65.72M | $72.77M |
| Total assets | $1.27B | $1.73B |
| Current liabilities | $1.08B | $1.15B |
| Short-term debt | $19.24M | $0 |
| Long-term debt | $15.75M | $34.90M |
| Total debt | $34.99M | $34.90M |
| Total liabilities | $1.14B | $1.26B |
| Shareholders' equity | $126.73M | $470.95M |
| Net debt | -$138.72M | -$153.33M |
| Shares outstanding | 16.59M | 412.19M |
| Cash flow statement | ||
| Operating cash flow | -$105.76M | -$57.78M |
| Capital expenditure | $13.24M | $13.25M |
| Free cash flow | -$119.00M | -$71.03M |
| Investing cash flow | $88.61M | $139.89M |
| Financing cash flow | -$2.99M | -$2.58M |
| Depreciation & amortization | $28.59M | $24.46M |
| Stock-based compensation | $49.12M | $50.66M |
Free plan shows the latest 2 periods; Pro shows all 7 🔒
· This company does not report gross profit in XBRL.
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.